MX2023004940A - Proceso para preparar compuestos de metanona heterocíclicos e intermediarios aza-biciclo de los mismos. - Google Patents
Proceso para preparar compuestos de metanona heterocíclicos e intermediarios aza-biciclo de los mismos.Info
- Publication number
- MX2023004940A MX2023004940A MX2023004940A MX2023004940A MX2023004940A MX 2023004940 A MX2023004940 A MX 2023004940A MX 2023004940 A MX2023004940 A MX 2023004940A MX 2023004940 A MX2023004940 A MX 2023004940A MX 2023004940 A MX2023004940 A MX 2023004940A
- Authority
- MX
- Mexico
- Prior art keywords
- aza
- bicyclo
- intermediates
- compounds
- methanone compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B49/00—Grignard reactions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020904060A AU2020904060A0 (en) | 2020-11-06 | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof | |
| PCT/AU2021/051310 WO2022094668A1 (en) | 2020-11-06 | 2021-11-05 | Process for preparing heterocyclic methanone compounds and aza-bicyclo intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023004940A true MX2023004940A (es) | 2023-09-12 |
Family
ID=81458249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023004940A MX2023004940A (es) | 2020-11-06 | 2021-11-05 | Proceso para preparar compuestos de metanona heterocíclicos e intermediarios aza-biciclo de los mismos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230416243A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4240740A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023548368A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230154789A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116981461A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021374232A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196642A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023001300A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302671A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004940A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022094668A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026509196A (ja) * | 2023-03-02 | 2026-03-17 | アクチノゲン メディカル リミテッド | アザ二環式ヘテロアリール化合物を調製するための流動化学プロセス |
| CN121969372A (zh) * | 2023-10-03 | 2026-05-01 | 射线质医疗有限公司 | 片剂制剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1732552A4 (en) * | 2004-01-20 | 2007-12-19 | Merck & Co Inc | 2,6-DISUBSTITUTED PIPERIDINES AS MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY |
| MY145633A (en) * | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
| ES2366058T3 (es) * | 2006-03-01 | 2011-10-14 | Theravance, Inc. | Compuestos de 8-azabiciclo[3.2.1]octano como antagonistas de los receptores opioides mu. |
| CA2738453C (en) * | 2008-10-23 | 2017-07-04 | Boehringer Ingelheim International Gmbh | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| DK2477983T3 (en) * | 2009-09-16 | 2015-06-29 | Univ Edinburgh | (4-phenyl-piperidin-1-yl) - [5-1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONFORBINDELSER AND THEIR USE |
| AU2010331927B2 (en) * | 2009-12-17 | 2013-10-10 | Merck Canada Inc. | Aminopyrimidines as Syk inhibitors |
| WO2011090935A1 (en) * | 2010-01-19 | 2011-07-28 | Merck Sharp & Dohme Corp. | PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS |
| BR112012027640B1 (pt) * | 2010-04-29 | 2021-08-03 | The University Of Edinburgh | Composto, composição farmacêutica, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 |
-
2021
- 2021-11-05 KR KR1020237018659A patent/KR20230154789A/ko active Pending
- 2021-11-05 AU AU2021374232A patent/AU2021374232A1/en active Pending
- 2021-11-05 EP EP21887915.3A patent/EP4240740A4/en active Pending
- 2021-11-05 IL IL302671A patent/IL302671A/en unknown
- 2021-11-05 MX MX2023004940A patent/MX2023004940A/es unknown
- 2021-11-05 WO PCT/AU2021/051310 patent/WO2022094668A1/en not_active Ceased
- 2021-11-05 CN CN202180088882.XA patent/CN116981461A/zh active Pending
- 2021-11-05 US US18/252,025 patent/US20230416243A1/en active Pending
- 2021-11-05 JP JP2023526903A patent/JP2023548368A/ja active Pending
- 2021-11-05 CA CA3196642A patent/CA3196642A1/en active Pending
-
2023
- 2023-05-04 CL CL2023001300A patent/CL2023001300A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4240740A4 (en) | 2024-12-11 |
| US20230416243A1 (en) | 2023-12-28 |
| CN116981461A (zh) | 2023-10-31 |
| EP4240740A1 (en) | 2023-09-13 |
| IL302671A (en) | 2023-07-01 |
| AU2021374232A9 (en) | 2024-09-26 |
| CA3196642A1 (en) | 2022-05-12 |
| WO2022094668A1 (en) | 2022-05-12 |
| CL2023001300A1 (es) | 2024-01-05 |
| JP2023548368A (ja) | 2023-11-16 |
| KR20230154789A (ko) | 2023-11-09 |
| AU2021374232A1 (en) | 2023-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5034398A (en) | 1H-indazole-3-carboxamide-N-2-azabicyclo[2.2.2]octanes useful for treating anxiety, psychosis, neuralgia, migraine and cluster headaches | |
| AU745964B2 (en) | 8-Azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACh receptors | |
| US5686463A (en) | Oxadiazoles useful in the treatment of senile dementia | |
| US4798829A (en) | 1-Azabicyclo[3,2,2]nonane derivatives having 5-HT receptor antagonist activity | |
| US4808588A (en) | Heterocyclic ureas and carbonates useful as pharmaceuticals | |
| US5541194A (en) | Certain 1-azabicyclo[2.2.1]heptanes and 1-azabicyclo[2.2.2]octanes | |
| US4822795A (en) | Pharmaceutically useful esters and amides | |
| AU617785B2 (en) | Spirocyclic compounds incorporating five-membered rings with two heteroatoms | |
| HU193725B (en) | Process for producing benzoic acid and indocarboxylic acid derivatives and pharmaceutical compositions containing them | |
| US7538132B2 (en) | Isoxazolo derivatives | |
| JP2007269811A (ja) | 化学的シナプス伝達の制御に有用なフロピリジン、チエノピリジン、ピロロピリジンおよび関連するピリミジン、ピリダジンおよびトリアジン化合物 | |
| AU2004249441B2 (en) | Novel 8-aza-bicyclo(3.2.1)octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
| CL2023001300A1 (es) | Proceso para preparar compuestos de metanona heterocíclicos e intermediarios aza-bicyclo de los mismos | |
| EP1638939A2 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
| US5324724A (en) | Compounds for the treatment of senile dementia | |
| MX2025009864A (es) | Proceso de quimica de flujo para preparar compuestos de heteroarilo aza-biciclico | |
| US5200413A (en) | Indolyl carboxamides useful treating migraine, cluster headache, trigeminal neuralgia or emesis | |
| US5470859A (en) | Azabicyclic compounds with muscarinic activity useful for treating dementia | |
| AU2004212166B2 (en) | 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
| CA2627546A1 (en) | 3 -monosubstituted tropane derivatives as nociceptin receptor ligands | |
| Zhai et al. | Construction of protected hydroxylated pyrrolidines using nitrogen-centered radical cyclizations | |
| IE84087B1 (en) | Novel compounds |